Originally Posted by
Balance
Psychic,
I use any company's information, projections, presentations etc as a guide - not as statements of truth which are going to eventuate. And I monitor carefully what the company asserts and says against developments as they happen. And I talk to competitors, suppliers, creditors, customers etc etc to get alternative and/or affirmative views.
The business/industry/market that PEB is in is very dynamic and becoming crowded (alerted to already by Snapiti) so PEB's competitive edge can only last so long.
There is an imperative need therefore for PEB to get traction and establish market positioning. PEB started its market positioning program in 2012 by using 'user programs' with the intention of shifting the program to full commercial relationships in 2013. Refer AR 2013. Assess and judge for yourself where PEB is at with that strategy of shifting user programs to commercial relationships.
Meanwhile, other players with deeper pockets, market presence and different strategies are entering and/or enhancing their products in the bladder cancer urine test market. It is not a stand still situation where PEB has the luxury of time (and money) to achieve its market positioning! This information is freely available - one only has to search and read!